Tobacco-specific nitrosamines, commonly called TSNAs, are a group of potent cancer-causing chemicals that form when natural tobacco alkaloids react with nitrogen-containing compounds during the curing, processing, and storage of tobacco. They rank among the most harmful substances in any tobacco product, whether smoked, chewed, or even passively inhaled. Two TSNAs in particular, known by the shorthand NNK and NNN, have drawn the most scientific attention because of their strong links to cancers of the lung, mouth, esophagus, and pancreas. What makes TSNAs especially concerning is that they are not simply inhaled and exhaled; they are absorbed into the body, chemically activated, and then directly damage DNA in ways that can trigger tumor growth.
How TSNAs Form in Tobacco
TSNAs do not exist in the living tobacco plant. They are created after the leaf is harvested, during the curing and fermentation stages that prepare tobacco for commercial use. The process begins when nitrosating agents, particularly nitrogen oxides, react with tobacco alkaloids like nicotine and nornicotine. Bacteria living on the tobacco leaf play a key role: certain nitrate-reducing species convert naturally present nitrate into nitrite, which then chemically reacts with the alkaloids to produce nitrosamines.1PubMed Central. An update on the formation in tobacco, toxicity and carcinogenicity of N ʹ-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone Because nicotine is by far the most abundant alkaloid in most tobacco varieties, it serves as the major precursor for these carcinogens.2JNCI: Journal of the National Cancer Institute. Tobacco-Specific Nitrosamines: Formation From Nicotine In Vitro and During Tobacco Curing and Carcinogenicity in Strain A Mice
The amount of TSNAs that end up in a finished tobacco product depends heavily on how the leaf is processed. Air-cured tobaccos, commonly used in cigarettes and chewing tobacco, tend to have higher TSNA levels than flue-cured varieties, because the slower drying process gives bacteria more time to convert nitrate to nitrite. Fire-cured tobaccos, used in some pipe and smokeless products, can also accumulate high levels because combustion gases contribute additional nitrogen oxides. Storage conditions matter too: warm temperatures and high humidity accelerate the chemical reactions that form TSNAs even after curing is complete.
From Chemical to Carcinogen Inside the Body
TSNAs are not immediately dangerous when they first enter the body. They require metabolic activation, a process carried out by enzymes in your tissues that inadvertently convert TSNAs into highly reactive molecules. For NNK, the key step is a reaction called alpha-hydroxylation, primarily carried out by enzymes in the cytochrome P450 family. One enzyme in particular, CYP2A13, which is expressed heavily in lung tissue, plays a dominant role in activating NNK. Research has shown that when CYP2A13 is present, NNK treatment causes a sharp increase in a specific type of DNA damage known as O6-methylguanine, which is directly linked to mutations.3PubMed. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation–a mammalian cell-based mutagenesis approach
The picture gets more complicated in different organs. In the esophagus, for instance, studies of human tissue samples found that while NNN was readily activated by esophageal enzymes, most samples did not activate NNK at all. This tissue-specific variation helps explain why different TSNAs are linked to cancers in different parts of the body. Work comparing esophageal tissue from people in the United States and from a high-risk region in China found that NNN activation rates were roughly twice as high in the Chinese samples, suggesting that individual and population-level differences in enzyme activity influence cancer susceptibility.4Carcinogenesis. Characterization of xenobiotic-metabolizing enzymes and nitrosamine metabolism in the human esophagus
Once activated, these reactive TSNA metabolites latch onto DNA and form what scientists call adducts, essentially molecular damage that alters the genetic code. When the cell tries to copy its DNA during division, these adducts cause misreadings. The mutations that result tend to follow distinctive patterns. In animal studies, NNK-induced lung tumors overwhelmingly carry a specific mutation in the K-ras gene, a well-known oncogene. In mice, roughly nine out of ten NNK-induced tumors showed this same characteristic genetic change.5Carcinogenesis. K-ras mutations in lung tumors from A/J and A/J×TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate The same pattern appeared in hamster models, where K-ras mutations were found in the vast majority of NNK-treated lung tumors.6Carcinogenesis. K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors In smokeless tobacco users, the reactive compounds from TSNAs also cause mutations in the p53 tumor suppressor gene and in RAS oncogenes, which are central players in human cancer development.7PubMed. From cultivation to cancer: formation of N-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implications
The Shift Toward Lung Adenocarcinoma
One of the most striking epidemiological changes in smoking-related cancer over the past several decades has been the rise of adenocarcinoma as the most common type of lung cancer among smokers in the United States. Adenocarcinoma forms in the small glandular cells in the outer regions of the lungs, rather than in the large airways where squamous cell carcinoma, historically the dominant type, tends to arise. Two factors are widely cited to explain this shift. The first is changes in cigarette design: filters, lower-tar formulations, and ventilation holes that led smokers to inhale more deeply, pushing smoke constituents farther into the peripheral lung. The second centers on NNK itself, which reliably induces adenocarcinoma in laboratory animals. The U.S. Surgeon General has concluded that there is “suggestive evidence” that both ventilated filters and increased levels of TSNAs have contributed to this trend.8Cancer Prevention Research. It Is Time to Regulate Carcinogenic Tobacco-Specific Nitrosamines in Cigarette Tobacco
Beyond the lungs, NNK has also been implicated in pancreatic cancer. Research in mouse models has shown that NNK accelerates the formation of precancerous pancreatic lesions and the progression to full pancreatic cancer, working through a signaling pathway that involves the protein CREB. When CREB was depleted in these experiments, tumor burden dropped significantly after NNK exposure, reinforcing the idea that the carcinogen actively drives tumor growth in the pancreas rather than merely initiating it.9Cancer Research. Tobacco Carcinogen–Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer
Smokeless Tobacco Is Not TSNA-Free
A common misconception is that avoiding smoke means avoiding the worst tobacco carcinogens. Smokeless tobacco products, including chewing tobacco, snuff, and various traditional preparations used around the world, contain TSNAs along with other harmful substances like polonium, formaldehyde, and heavy metals.10PubMed Central. Risk for oral cancer from smokeless tobacco Reviews of the global evidence have found that smokeless products with high TSNA levels carry a high risk of oral cancer.11Cancer Prevention Research. Oral Cancer Risk Assessment for Different Types of Smokeless Tobacco Products Sold Worldwide: A Review of Reviews and Meta-analyses
The TSNA content of smokeless products varies enormously depending on how they are made. Traditional dry snuff and some moist snuff products can contain extremely high concentrations. At the other end of the spectrum, Swedish snus manufactured under the GothiaTek quality standard, a voluntary set of manufacturing guidelines introduced in the late 1990s, tends to have much lower TSNA levels. This standard emphasizes improved production techniques and careful selection of raw materials.12PubMed Central. Swedish snus and the GothiaTek® standard Chemical analysis has confirmed that products conforming to GothiaTek had some of the lowest TSNA levels of any oral tobacco product tested, while certain American snus brands and some European brands exceeded the GothiaTek thresholds for NNN and NNK. Even those higher-level snus products, though, contained far less than conventional moist snuff or dry snuff.13PLOS ONE. Chemical analysis of snus products from the United States and northern Europe This variation across product categories is one reason why blanket statements about smokeless tobacco risk can be misleading; the TSNA dose a person receives depends heavily on the specific product.
Secondhand Smoke and the Surprising Problem of Thirdhand Smoke
You do not have to use tobacco yourself to be exposed to TSNAs. Secondhand smoke is a well-established source. Studies of nonsmokers have found that those exposed to secondhand smoke carry significantly higher levels of NNAL, a metabolite of NNK that serves as a reliable biomarker for TSNA exposure, in their urine. In one large study, nonsmokers in the secondhand-smoke-exposed group were roughly two and a half times more likely to have high urinary NNAL levels compared to unexposed nonsmokers, with the effect being even stronger in women.14PubMed Central. Exposure to Secondhand Smoke and a Tobacco-Specific Carcinogen in Non-Smokers Even brief outdoor exposure matters: nonsmokers who spent time outside a bar where smoking was occurring showed measurably elevated urinary NNAL the next day.15Environmental Health Perspectives. Exposure to Secondhand Smoke Outside of a Bar and a Restaurant and Tobacco Exposure Biomarkers in Nonsmokers
Adolescents appear to be particularly affected. A study of Korean teenagers found that those exposed to secondhand smoke had significantly higher urinary NNAL levels than their unexposed peers, and the risk was dramatically amplified when the exposure happened at home. Girls exposed to secondhand smoke at home had more than twenty times the odds of elevated NNAL levels compared to unexposed girls.16Journal of Korean Medical Science. Association between Second-hand Smoke Exposure and Urinary NNAL Level in Korean Adolescents The home environment, with its enclosed spaces and repeated exposure, concentrates the dose in ways that outdoor or occasional encounters do not.
Perhaps more surprising is thirdhand smoke, the residue left behind on surfaces after smoking has stopped. Nicotine from tobacco smoke absorbs readily into carpets, upholstery, walls, and clothing. When that deposited nicotine reacts with nitrous acid, a common indoor air pollutant produced by gas stoves and vehicle exhaust that seeps indoors, it generates TSNAs directly on those surfaces. Laboratory experiments showed more than a tenfold increase in surface-bound TSNAs after exposing secondhand-smoke-coated material to nitrous acid for just three hours.17PubMed Central. Formation of carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to potential thirdhand smoke hazards This means that simply airing out a room after someone has smoked does not eliminate the TSNA risk; the residue on surfaces continues to produce carcinogens long after the visible smoke clears. Infants and toddlers who crawl on floors and put objects in their mouths may face outsized exposure from these contaminated surfaces.
TSNAs in E-Cigarettes and Nicotine Products
Because TSNAs form from tobacco alkaloids during processing, any product derived from tobacco leaf can carry trace amounts. E-cigarettes, which use nicotine liquid typically extracted from tobacco, are no exception. Testing of e-cigarette liquids has detected TSNAs, and those nitrosamines transfer into the aerosol the user inhales, with measured aerosol levels closely matching the amounts predicted from the liquid concentrations.18PubMed Central. Tobacco-Specific Nitrosamines in Electronic Cigarettes: Comparison between Liquid and Aerosol Levels The absolute levels in e-cigarettes are generally far lower than in combustible cigarettes, but they are not zero. For someone switching from cigarettes to vaping, this represents a large reduction in TSNA exposure. For a never-smoker who takes up vaping, it represents a new exposure that would otherwise not exist.
Nicotine replacement therapies like patches, gums, and lozenges can also contain trace TSNAs because the nicotine in them is extracted from tobacco. The concentrations are vanishingly small compared to cigarettes or even e-cigarettes, and regulators have generally considered these levels toxicologically insignificant. Still, the presence of TSNAs in any nicotine product derived from tobacco is an inherent consequence of how these chemicals form.
Endogenous Formation and an Unexpected Wrinkle
TSNAs can also form inside the body itself. Rat studies have shown that when animals are given nicotine and sodium nitrite together, TSNAs appear in their urine, demonstrating that endogenous nitrosation of tobacco alkaloids is possible. NNN was detected in the urine of rats given nicotine and sodium nitrite, likely formed through nitrosation of nornicotine, a metabolite of nicotine.19Carcinogenesis. Evidence for endogenous formation of tobacco-specific nitrosamines in rats treated with tobacco alkaloids and sodium nitrite This raises questions about whether any nicotine user, regardless of the delivery method, might generate some TSNAs internally, particularly if their diet or physiology provides enough nitrite for the reaction to occur. The amounts detected in these animal studies were small relative to what a smoker inhales directly, but the finding is a reminder that TSNA exposure cannot be fully eliminated simply by cleaning up the product.
TSNAs and Pregnancy
Tobacco carcinogens, including TSNAs, do not stay confined to the smoker’s lungs or bloodstream. Research has confirmed that these compounds can cross the placenta. Analysis of placental tissue from smokers has identified TSNAs along with other tobacco-derived carcinogens, including polycyclic aromatic hydrocarbons and aromatic amines.20Journal of Pharmaceutical and Biomedical Analysis. Toxic compounds from tobacco in placenta samples analyzed by UPLC-QTOF-MS The placenta acts as a barrier to many harmful substances, but it is clearly not impervious to TSNAs. This means the developing fetus of a smoking mother, or potentially of a mother exposed to heavy secondhand smoke, receives some dose of these carcinogens during a period of rapid cell division when DNA damage can have outsized consequences.
Measuring TSNA Exposure
Scientists track TSNA exposure in people by measuring NNAL in urine. NNAL is a metabolite of NNK and is remarkably stable in the body, with a half-life of several weeks, making it a reliable marker of cumulative exposure rather than just a snapshot of recent use. Large population surveys have used urinary NNAL to compare exposure across groups: smokers versus nonsmokers, users of different product types, and people in different environmental settings.21PubMed. TSNA Exposure: Levels of NNAL Among Canadian Tobacco Users This biomarker approach has been crucial for demonstrating that secondhand smoke delivers a meaningful TSNA dose, something that would be hard to prove from air measurements alone.
On the analytical side, measuring TSNAs in tobacco products themselves has evolved considerably. Older methods relied on gas chromatography with specialized detectors that could identify nitrogen-containing compounds but struggled to distinguish between similar molecules and required extensive sample preparation. Newer liquid chromatography methods paired with tandem mass spectrometry offer much better sensitivity and selectivity, allowing researchers to detect and quantify individual TSNAs at very low concentrations. This improved analytical capability has been essential for comparing products and enforcing potential regulatory standards.
Regulatory Efforts to Limit TSNA Levels
Given the strong evidence linking TSNAs to cancer, regulators have begun exploring limits on how much of these chemicals tobacco products can contain. The FDA has proposed a product standard that would cap NNN levels in smokeless tobacco sold in the United States.22PubMed Central. Reducing tobacco-related harm: FDA’s proposed product standard for smokeless tobacco The rationale is straightforward: since TSNA levels vary widely across products and depend largely on manufacturing choices, setting a maximum could force the highest-TSNA products off the market or compel manufacturers to adopt cleaner processes. The Swedish snus industry’s voluntary GothiaTek standard demonstrates that low-TSNA manufacturing is technically achievable without eliminating the product category.
Setting a limit for cigarettes is trickier because combustion itself generates additional harmful compounds, and reducing TSNAs in the tobacco filler would not eliminate the many other carcinogens in cigarette smoke. Still, some researchers have argued that even partial TSNA reduction in cigarettes could meaningfully lower cancer risk at a population level, given that NNK is one of the most potent lung carcinogens in tobacco smoke and that its levels in U.S. cigarette tobacco have increased over several decades. Whether TSNA-specific regulation can deliver measurable public health gains remains an open question, but the scientific case for treating these compounds as a priority target within tobacco regulation is strong and growing.
Why TSNA Levels Vary So Much Across Products
If you compared the TSNA content of every tobacco product on the global market, you would find a range spanning several orders of magnitude. At the low end sit products like GothiaTek-compliant Swedish snus. At the high end are some traditional smokeless products used in South Asia and parts of Africa, where fermentation and curing methods have not been optimized to minimize nitrosamine formation. Cigarettes fall somewhere in between, though even within the cigarette category, brands and blends differ. Several factors drive this variation:
- Curing method: Air curing produces more TSNAs than flue curing, because the longer process and higher microbial activity allow more nitrosation to occur.
- Bacterial load: Tobacco with more nitrate-reducing bacteria on its surface generates more nitrite, the key chemical precursor. Agricultural practices and post-harvest handling affect this load.
- Nitrate content of the leaf: Tobacco grown in high-nitrogen soil or heavily fertilized tends to have more nitrate available for conversion to nitrite.
- Storage and aging: Longer storage, especially under warm and humid conditions, gives TSNAs more time to accumulate. Products that sit in warehouses or on store shelves for months may have higher levels than freshly manufactured ones.
- Pasteurization: Some modern snus manufacturers heat-treat their product in a step similar to pasteurization, which kills bacteria and halts further TSNA formation. Products that skip this step, like many traditional moist snuffs, continue accumulating TSNAs after packaging.
Understanding these drivers makes one thing clear: TSNA levels are not fixed characteristics of “tobacco.” They are outcomes of agricultural and manufacturing decisions. Products can be made with dramatically lower TSNA levels, as the Swedish snus industry has demonstrated, though this does not make any tobacco product safe in absolute terms. The goal from a public health standpoint is to push down TSNA exposure wherever possible while recognizing that eliminating tobacco use entirely remains the most effective risk reduction.